Almac lands GMP certification for Irish site
Following an inspection at its Ireland site, Almac received compliance certification for its Almac Adapt Just in Time’ clinical packaging and labelling manufacturing services.
Following an inspection at its Ireland site, Almac received compliance certification for its Almac Adapt Just in Time’ clinical packaging and labelling manufacturing services.
Lack of reproducibility in drug discovery has thrown the industry into crisis, scientists from Molecule and Arctoris claim, and suggest their discovery platform answers this challenge.
The ICER plans to harness the company’s technology to expand use of real-world evidence.
Grifols set to purchase all assets of Aradigm, including its Phase III antibiotic for respiratory diseases, after the developer filed for bankruptcy.
According to the French company, the spinout would enter the market as the second largest API producer globally.
A group of 24 companies is set to support blockchain technology to ensure compliance with the FDA’s DSCSA requirements and to tackle counterfeiting.